Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ling Yang, Liangliang Zhang & Zhu Luo. (2023) Comparative Pharmacokinetics and Bioequivalence Evaluation of Two Formulations of Pramipexole Dihydrochloride Extended-Release Tablets in Healthy Chinese Subjects Under Fasted and Fed States: A Randomized, Open-Label, Single-Dose, Two-Period Crossover Clinical Trial. Drug Design, Development and Therapy 17, pages 2369-2381.
Read now
Read now
Cornelis J Van der Schyf. (2015) Rational drug discovery design approaches for treating Parkinson’s disease. Expert Opinion on Drug Discovery 10:7, pages 713-741.
Read now
Read now
Articles from other publishers (2)
Samuele Ciceri, Patrizia Ferraboschi, Paride Grisenti, Shahrzad Reza Elahi, Carlo Castellano, Matteo Mori & Fiorella Meneghetti. (2020) (S)-Pramipexole and Its Enantiomer, Dexpramipexole: A New Chemoenzymatic Synthesis and Crystallographic Investigation of Key Enantiomeric Intermediates. Catalysts 10:8, pages 941.
Crossref
Crossref
Alessandra Bonito-Oliva, Débora Masini & Gilberto Fisone. (2014) A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions. Frontiers in Behavioral Neuroscience 8.
Crossref
Crossref